Comparison Overview
Novartis Science
Novartis Science
250 Massachusetts Avenue, Cambridge, 02139, US
Last Update: 25/12/2025
Novartis is an innovative medicines company with research and development at its core. Our R&D engine powers an industry-leading pipeline dedicated to delivering transformative medicines to fight disease, restore possibilities and help people live life on their own term...
Novartis
Novartis Campus, Basel, 4002, CH
Last Update: 07/10/2026
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million pe...
Compliance Ranges Comparison
Novartis Science
Novartis
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Novartis Science in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Novartis has 0.99% fewer incidents than the average of all companies with at least one recorded incident.
Incident History - Novartis Science (X = Date, Y = Severity)
Novartis Science cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Novartis (X = Date, Y = Severity)
Novartis cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Novartis Science
Novartis
FAQ
Latest Global CVEs
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.
IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.
IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.
IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.